Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.900
-0.030 (-1.55%)
At close: Sep 29, 2025, 4:00 PM EDT
1.890
-0.010 (-0.53%)
After-hours: Sep 29, 2025, 5:02 PM EDT
APUS Employees
Apimeds Pharmaceuticals US had 2 employees as of December 31, 2024.
Employees
2
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,854,372
Market Cap
23.89M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
APUS News
- 13 days ago - Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development - Business Wire
- 17 days ago - Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program - Business Wire
- 5 weeks ago - Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs - Business Wire
- 2 months ago - Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division - Business Wire
- 5 months ago - Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering - GlobeNewsWire
- 5 months ago - U.S. IPO Weekly Recap: Sizable Insurance IPOs Deliver Solid Trading - Seeking Alpha
- 5 months ago - Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Inflammation-focused biotech Apimeds Pharmaceuticals US files for a $12 million IPO - Renaissance Capital